G
Galectin Therapeutics Inc. (GALT)
NCM – Real vaqt narxi. Valyuta: USD
4.99
+0.76 (17.97%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.96
-0.03 (-0.56%)
Bozordan keyin: Jun 26, 2026, 7:50 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.99
+0.76 (17.97%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.96
-0.03 (-0.56%)
Bozordan keyin: Jun 26, 2026, 7:50 PM EDT
Galectin Therapeutics Inc., klinik bosqichdagi biopilashuv kompaniyasi, fibroz kasalliklari va saraton uchun yangi davolash usullarini yaratish uchun dori ishlab chiqish bilan shug'ullanadi. Kompaniyaning asosiy mahsulot nomzodi belapektin (GR-MD-02) hisoblanadi, bu galectin-3 inhibitori bo'lib, u ilg'or fibrozli MASH bemorlarida 2-bosqich klinik tadqiqotda va kompensatsiyalangan sirroz va portal gipertenziyali MASH bemorlarida ikkinchi 2b-bosqich klinik sinovida. Kompaniya SBH Sciences, Inc. tomonidan birgalikda egalik qilinadigan qo'shma korxonaga ega bo'lib, u og'iz orqali yuboriladigan galectin-3 ning kichik organik molekulyar inhibitorlarini tadqiq qilish va ishlab chiqish uchun mo'ljallangan. Kompaniya ilgari Pro-Pharmaceuticals, Inc. nomi bilan tanilgan va 2011 yil may oyida Galectin Therapeutics Inc. nomini o'zgartirgan. Galectin Therapeutics Inc. 2000 yilda tashkil etilgan va Norcross, Jorjiya shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Khurram Jamil M.D. | Chief Medical Officer |
| Mr. Jack W. Callicutt CPA | CFO, Treasurer & Corporate Secretary |
| Mr. Jim Wilkins Ph.D. | Head of CMC & Pharmaceutical Development |
| Mr. Joel Lewis CPA | President & CEO |
| Mr. Robert Tritt J.D. | General Counsel |
| Ms. Beth Knowles | Executive Assistant & Officer Manager |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-23 | 8-K | ef20076593_8k.htm |
| 2026-05-15 | 8-K | ef20073003_8k.htm |
| 2026-05-15 | 10-Q | ef20070490_10q.htm |
| 2026-04-08 | CORRESP | filename1.htm |
| 2026-03-31 | 8-K | ef20068722_8k.htm |
| 2026-03-31 | 10-K | ef20060823_10k.htm |
| 2026-03-17 | 8-K | ef20068034_8k.htm |
| 2026-01-21 | 8-K | ef20063365_8k.htm |
| 2026-01-12 | 8-K | ef20062754_8k.htm |
| 2025-12-19 | 8-K | ef20061484_8k.htm |